当前位置:首页 - 行情中心 - 广济药业(000952) - 财务分析 - 利润表

广济药业

(000952)

  

流通市值:27.31亿  总市值:27.31亿
流通股本:2.52亿   总股本:2.52亿

利润表

按照会计年度查询:
报告期2019-09-302019-06-302019-03-312018-12-31
一、营业总收入555,342,750.75365,490,654.33180,917,718.37843,830,942.08
营业收入555,342,750.75365,490,654.33180,917,718.37843,830,942.08
二、营业总成本460,127,938.32290,236,888.92143,759,770.01641,944,816.74
营业成本274,125,773.25176,693,220.4891,940,050.97364,351,370.67
营业税金及附加11,865,668.518,191,822.884,249,259.9623,117,113.26
销售费用28,511,071.219,131,570.17,403,552.6537,273,210.65
管理费用86,789,046.9548,876,280.5521,862,481.87114,245,995.93
财务费用24,277,958.1217,092,165.538,300,908.3733,836,869.43
资产减值损失-1,489,627.13-1,009,492.69761,689.44,435,927.82
三、其他经营收益3,786.1510,270.24-15,335.42--
允许价值变动净收益--------
投资净收益-3,046,697.67-1,591,545.3-1,139,042.15-2,211,552.8
联营、合营企业投资收益-3,166,697.67-1,711,545.3-1,139,042.15-2,411,552.8
汇兑净收益--------
四、营业利润124,249,461.375,833,795.2537,619,141.91211,143,484.32
营业外收入1,493,978.21,490,122.0893,416.22,038,378.59
营业外支出570,854.07319,307.96262,872.966,117,290.56
非流动资产处置净损失--------
五、利润总额125,172,585.4377,004,609.3737,449,685.15207,064,572.35
所得税23,157,076.4315,300,245.857,597,553.6233,654,638.82
未确认的投资损失--------
六、净利润(百万元)104.262.7930.42171.73
少数股东损益-2,183,589.03-1,087,597.4-565,916.781,681,024.37
归属于母公司股东的净利润104,199,098.0362,791,960.9230,418,048.31171,728,909.16
七、每股收益0.420.250.120.68
基本每股收益0.420.250.120.68
稀释每股收益0.420.250.120.68
TOP↑